With the recent FDA approval of the first WSI scanner for primary diagnosis, digital pathology adoption is happening at an accelerated pace. Labs are recognizing the broad benefits of going digital, creating exciting opportunities for new revenue streams and broadening the impact that pathology has on cancer diagnosis and research.

Proscia’s award-winning software delivers applications for clinical use-cases and sets the stage for AI-based computational pathology.

  • Learn how Proscia’s modular software can help you adopt digital pathology at your own pace
  • See some of the powerful clinical applications of Proscia’s platform, including consultation and digital IHC
  • Hear from a Proscia customer about adopting digital pathology and how it’s helping transform their lab
  • Explore how Proscia drives precision medicine and computational pathology in your lab with machine learning and artificial intelligence (AI) techniques

*Proscia software is not intended for primary diagnostic use.